lexaria glp 1 Bioscience Finds its Niche in the Lucrative GLP-1 Market Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical

Over the years its transformedand not for the better

Al-Awqati 2012

134 Our pipeline

it was approved two decades ago as an add-on therapy to treat patients with diabetes who use insulin but cannot achieve desired blood sugar levels

Sign up for our newsletterStay ahead of development by receiving our newsletter on the latest sector knowledge.E-mail addressClearContinueI want to receive customized email newsletters from Watch Medier A/S, including information about our brands and group companies, conferences, courses, networking, competitions and digital services."n"nWith my consent, I also agree to the processing of my personal data and that information about my interaction with marketing messages (such as opening and reading) is collected using tracking pixels and similar technologies